BusinessPhoto: Hindu HealthSC Seeks Wider Drug Price Controls Amid ₹8,447 Crore Overcharging Claims
The Supreme Court is pushing for broader price controls on medicines as ₹8,447 crore in overcharging claims remain unresolved. The National Pharmaceutical Pricing Authority (NPPA), India's drug-price regulator, is actively pursuing companies involved in past overcharging cases to ensure fair pricing in the pharmaceutical sector.
Hindu Health·




